CKW Financial Group’s Wave Life Sciences WVE Stock Holding History

CKW Financial Group’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-150	Closed	-$1K	–	254
2021 Q2	$1K	Buy	+150	New	+$980	﹤0.01%	234

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

CKW Financial Group's WVE Position: Q3 2021 in Review

CKW Financial Group sold out of Wave Life Sciences (WVE) in Q3 2021, closing a stake of 150 shares — an estimated $1K sold.

CKW Financial Group first reported a position in WVE in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 88 funds tracked by Wall St. Rank hold WVE as of Q3 2021.

CKW Financial Group reported no remaining Wave Life Sciences position as of Q3 2021 after selling out during the quarter.
CKW Financial Group sold 150 Wave Life Sciences shares in Q3 2021, an estimated $1K.
CKW Financial Group first reported a position in Wave Life Sciences in Q2 2021 and held it in 1 quarter.
CKW Financial Group's Wave Life Sciences position peaked at $1K in Q2 2021.
88 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2021.

Based on CKW Financial Group's 13F filing for Q3 2021, filed 12 Nov 2021.